At the news
? NEUTRALIMPACT 2/10 144 filed Nov 3, 2026 at 15:21 ET
Two Twist Bioscience officers filed Form 144 notices on November 3, 2026, signaling intent to sell shares. CFO Dennis Cho plans to sell 949 shares (~$128K) and Chief Commercial Officer Patrick Finn plans to sell 2,565 shares (~$347K), both to cover tax obligations from vested equity awards. The sales are small relative to the company's $11.5B market cap and follow a pattern of insider sales over the prior three months.
- CFO Dennis Cho filed Form 144 to sell 949 shares valued at ~$128,496
- CCO Patrick Finn filed Form 144 to sell 2,565 shares valued at ~$347,305
- Both sales are to cover tax obligations from restricted stock vesting on 11/02/2026
- Cho has sold shares on 7 prior occasions since August 2026 totaling ~$5.6M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access